IFN level assessed by ultrasensitive detection technology in myositis patient: A promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome - Archive ouverte HAL Accéder directement au contenu
Communication Dans Un Congrès Année : 2018

IFN level assessed by ultrasensitive detection technology in myositis patient: A promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome

Karim Dorgham
  • Fonction : Auteur
Darragh Duffy
  • Fonction : Auteur
Perrine Guillaume-Jugnot
  • Fonction : Auteur
  • PersonId : 1122898
Guy Gorochov
  • Fonction : Auteur
Jean-Hugues Salmon
  • Fonction : Auteur

Dates et versions

hal-03831328 , version 1 (26-10-2022)

Identifiants

Citer

Loïs Bolko, Ségolène Toquet, Océane Landon-Cardinal, Karim Dorgham, Céline Anquetil, et al.. IFN level assessed by ultrasensitive detection technology in myositis patient: A promising biomarker of disease activity in dermatomyositis and anti-synthetase syndrome. American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting, ACR/ARHP 2018, Oct 2018, Chicago, United States. pp.1-3584, ⟨10.1002/art.40700⟩. ⟨hal-03831328⟩
16 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More